Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Upadacitinib effectively treats psoriasis and lichen planus together.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Adalimumab can cause complete hair loss in rare cases.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Belimumab may cause hair loss in lupus patients.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Enhancing immune response can improve cancer treatment effectiveness.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Rituximab can cause skin issues, but baricitinib may help improve them.

Dupilumab may help regrow hair in people with atopic dermatitis.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.